Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Interventional × Indolent Non-Hodgkin Lymphoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1130 Carcinoma, Non-Small-Cell Lung 710 Neoplasms 697 Colorectal Neoplasms 671 Carcinoma, Hepatocellular 531 Stomach Neoplasms 525 Prostatic Neoplasms 444 Lung Neoplasms 412 Pancreatic Neoplasms 370 Rectal Neoplasms 293 Recurrence 289 Neoplasm Metastasis 276 Leukemia, Myeloid, Acute 267 Multiple Myeloma 253 Colonic Neoplasms 250 Ovarian Neoplasms 241 Esophageal Neoplasms 237 Uterine Cervical Neoplasms 236 Lymphoma 236 Melanoma 224 Head and Neck Neoplasms 221 Brain Neoplasms 182 Precursor Cell Lymphoblastic Leukemia-Lymphoma 181 Lymphoma, Large B-Cell, Diffuse 170 Nasopharyngeal Carcinoma 164 Leukemia 158 Lymphoma, Non-Hodgkin 151 Glioblastoma 149 Liver Neoplasms 145 Urinary Bladder Neoplasms 140

Interventions

obinutuzumab 1 ibrutinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02689869 2021-05-07

Alternative

Ludwig-Maximilians - University of Munich

Phase 2 Unknown

Indolent Non-Hodgkin Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡